Strive partners with commercial and Medicare Advantage payors, Medicare, health systems, and physicians through flexible value-based payment arrangements, including assumption of total cost-of-care risk. The company's innovative clinical model has reduced hospital admissions by 41%, re-admissions by 30% and total cost of care by 20%. In September 2025, Strive raised $300 million in Series D equity funding and secured $250 million in debt financing for a combined $550 million capital raise.
Cyborg Score Rationale
Strive demonstrates strong market positioning as the national leader in value-based kidney care with proven clinical outcomes and substantial recent funding (September 2025). The company has achieved meaningful impact metrics (41% admission reduction, 30% readmission reduction) and operates in a high-growth specialty care segment. Strategic backing from tier-one investors and operational scale (700+ employees) support execution capability.
Top Insights
Raised $550 million in combined capital (September 2025): $300M Series D equity from NEA, CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Redpoint, and institutional investors; plus $250M in debt financing
Clinical model demonstrates significant cost and utilization reduction: 41% reduction in hospital admissions, 30% reduction in readmissions, and 20% reduction in total cost of care
Integrated platform combines nurse practitioner-led care teams (Kidney Heroes), machine learning predictive analytics (CareMultiplier), and local provider integration across all disease stages
Competes directly with Monogram Health and Somatus in specialty chronic disease management; positioned as ranked 1st among 6 active competitors
Named Competitors
Monogram Health — Value-based specialty care management
Somatus — Kidney disease and chronic condition management
Koda Health — Specialty care value-based models
Accuryn — Healthcare analytics and care optimization
Recent Developments
(September 2025) Raised $550 million capital: $300M Series D equity round led by NEA, plus $250M debt financing from strategic and institutional investors
(July 2025) Expanded executive leadership: Appointed Tom Hawkes as CTO and Amit Trivedi as Chief Actuary
(2026) Operating at scale with 700+ employees across integrated care delivery and technology operations
Open the full interactive Strive Health report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.